---
type: "Topics"
locale: "en"
url: "https://longbridge.com/en/topics/45076594.md"
description: "Three profit themes: AI computing power, weight-loss drugs, and energyFollowing Jensen Huang's resignation, the market is re-evaluating NVIDIA's valuation, bringing a larger question to the surface: if cloud providers continue investing in AI, whose profits will these incremental expenditures ultimately become? Meanwhile, weight-loss drugs and traditional energy each have their own profit cycles. Looking at these nine companies together, what truly warrants comparison is their respective growth drivers.I. AI Infrastructure: From GPUs to advanced packaging, five companies are earning money from different segmentsNVIDIA's ($NVIDIA(NVDA.US)) core advantage lies in its CUDA ecosystem and its ability to integrate GPUs, networking, and software into complete systems. With Chief Financial Officer Colette Kress serving as interim CEO, the next focus is whether new product deliveries and customer deployments maintain their original pace. AMD ($AMD(AMD.US)) competes for more data center business with its Instinct GPUs and EPYC server CPUs. The share it captures depends on whether customers can scale trials and small-scale deployments into broader production environments.Microchip ($Micron Tech(MU.US)) benefits from the growing demand for high-bandwidth memory (HBM) and DRAM in AI servers. As single-server configurations include more memory, the product mix and pricing will directly impact margins. Broadcom ($Broadcom(AVGO.US)) works on both custom AI chips and data center networking. As major cloud providers prioritize in-house chip development, Broadcom sees greater opportunities in assisting with design and connecting large-scale clusters. TSMC ($Taiwan Semiconductor(TSM.US)) controls advanced process and packaging capacity, serving various chip designers simultaneously; its growth hinges on the expansion of high-end capacity and customer wafer start schedules.II. Pharmaceuticals: Eli Lilly's growth depends on patient accessEli Lilly's ($Eli Lilly(LLY.US)) growth is driven by the diabetes drug Mounjaro and the weight-loss drug Zepbound. The extent to which demand translates into revenue depends on whether production capacity can keep up, insurance coverage expands, and actual pricing evolves. In the next phase, whether the pipeline can broaden its applicable patient population will also influence how high the market values Eli Lilly.III. Energy: Same oil business, but oil prices and refining margins affect players differentlyExxonMobil ($ExxonMobil(XOM.US)) and Chevron ($Chevron(CVX.US)) are integrated energy companies. Rising crude oil prices generally benefit upstream operations, but the final cash available for dividends and buybacks depends on production volume, costs, capital expenditures, and downstream performance.Marathon Petroleum's ($Marathon Petroleum(MPC.US)) profitability is more directly impacted by refining margins—the spread between the selling price of finished products like gasoline and diesel and the cost of crude oil procurement. Even if crude prices rise, if finished product prices don't keep pace, refining profits may be squeezed. For this company, refining margins, utilization rates, and maintenance schedules offer better explanatory power than looking at oil prices alone.If you could only track one metric over the next quarter, would you choose cloud providers' AI capex, insurance coverage for weight-loss drugs, or refining margins? Which is most likely to prompt the market to re-estimate these companies' profits?"
datetime: "2026-11-14T19:20:02.000Z"
locales:
  - [en](https://longbridge.com/en/topics/45076594.md)
  - [zh-CN](https://longbridge.com/zh-CN/topics/45076594.md)
  - [zh-HK](https://longbridge.com/zh-HK/topics/45076594.md)
author: "[辰逸](https://longbridge.com/en/profiles/16318663.md)"
generator: "portal-rs"
---

# Three profit themes: AI computing power, weight-lo…


### Related Stocks

- [CVX.US](https://longbridge.com/en/quote/CVX.US.md)
- [NVDA.US](https://longbridge.com/en/quote/NVDA.US.md)
- [MU.US](https://longbridge.com/en/quote/MU.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [XOM.US](https://longbridge.com/en/quote/XOM.US.md)
- [HBM.US](https://longbridge.com/en/quote/HBM.US.md)
- [STI.US](https://longbridge.com/en/quote/STI.US.md)
- [MPC.US](https://longbridge.com/en/quote/MPC.US.md)
- [AVGO.US](https://longbridge.com/en/quote/AVGO.US.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**